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ABSTRACT 
      The eastern oyster, Crassostrea virginica, is an economically important 
aquaculture species in the USA, but several diseases, such as Dermo and MSX, have 
an impact on production. Efforts have been made to develop disease-resistant oyster 
lines using selective breeding techniques based on phenotype; however, achievement 
of the desired trait is hindered by the inability to maintain consistent and intense 
selection pressure in field trials. Marker-Assisted Selection (MAS) offers an effective 
alternative to traditional breeding techniques by selecting based on genetic markers 
associated with disease resistance, which can be done even in the absence of disease-
related selection pressure.  The greatest challenge in applying MAS is to identify 
markers that are consistently associated with the disease-resistant phenotype.   In this 
study, 20 previously published microsatellite markers, including 8 located in regions 
previously associated with disease resistance were used to genotype and compare 
oyster populations of the same stock (NEH-RI) deployed in 2012 at two sites (York 
River, Virginia and Cape Shore, New Jersey) before and after a disease-caused 
mortality period (March – November 2013). Two markers located in disease-resistant 
QTLs (Cv02i23, Cvi1g3, and RUCV 97) exhibited significant post-mortality allelic 
distribution shifts in one site but not the other. Significant differences in allelic 
distribution before and after selection were detected in 3 markers with no prior 
evidence of association with disease resistance at either both sites (RUCV270 and 
RUCV 68) or one site (RUCV 27). These results strengthen the evidence associating 
markers Cv02i23, Cvi1g3, and RUCV97 with the disease-resistant phenotype and 
 
 
suggest that markers RUCV270, RUCV68 and RUCV 27 warrant further investigation.  
Additional genetic and functional genomic analyses are required to determine whether 
these markers are suited for MAS.    
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INTRODUCTION 
Disease management in oyster populations 
 Eastern oysters are a major part of the aquaculture industry in the United States 
of America (US).  In 2012, oyster production in the US totaled over 23 million pounds 
in production, with over 100 million dollars’ worth of value (NOAA 2014). However, 
maximum production is impeded by mortalities caused by diseases such as 
Multinucleated Sphere Unknown (MSX), Seaside Organism disease (SSO), Dermo, 
and Roseovarius Oyster Disease (ROD, a.k.a. juvenile oyster disease). Among these 
diseases, MSX and Dermo have the widest geographical range and thus have the 
largest impact on oyster production. Each disease alone can cause up to 90% mortality 
in an oyster population (Yu and Guo 2006, Burreson et al. 2000). While a high 
parasite load of Dermo or MSX can lead to mass mortality, a lighter burden of the 
parasites has negative sub-lethal effects on the oysters, including lowered condition 
index and reduced reproductive output (Ford and Smolowitzv 2007, Dittman et al. 
2001, Ford and Figueras 1988). Dermo and MSX are caused by the protozoan 
parasites Perkinsus marinus and Haplosporidium nelsoni respectively (Ewart and Ford 
1993). They affect oyster populations on the Atlantic coast of the United States from 
Maine to Florida, but Delaware Bay and Chesapeake Bay areas are where they hit the 
hardest (Burreson et al. 2000, Ford and Haskin 1982). With the increase in sea surface 
temperature due to climate change, MSX and Dermo have been observed to extend 
their range to the northeastern US coast and to cause mortalities in this region (Cook et 
al. 1997, Ford and Smolowitz 2007).  
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Oyster farmers utilize several strategies to avoid Dermo/MSX-related mortality 
events. Neither Dermo nor MSX proliferate in low temperature (below 18 ℃ ) and low 
salinity (below 10 psu) environments (Ewart and Ford 1993, Cook et al. 1998).  It has 
been found that altering the timing of seeding could lower mortality caused by MSX. 
Oysters deployed late in the season when temperature is falling generally has a lower 
level of disease intensity and mortality would not start until the following spring 
(Ewart and Ford 1993). Another approach is to take the advantage of MSX and Dermo 
pathogens’ poor tolerance of low salinity and deploy oysters at sites of low salinity 
(Paynter and Burreson 1991). However, this approach sacrifices growth since oysters 
do not grow as well in low temperature or salinity sites (Ewart and Ford 1993, Paynter 
and Burreson 1991). Although MSX and Dermo prevalence and intensity of infection 
can be reduced with cold winters (both diseases) or low salinity (e.g. caused by 
freshwater influx after storms, mainly for MSX), disease prevalence and intensity 
increase as soon as environmental conditions become favorable to both parasite and 
oyster growth during summer and fall seasons (Ewart and Ford 1993). Farming 
practices alone are insufficient to prevent economic losses to disease. 
     Artificial selection for disease resistance is another approach being employed to 
mediate the negative impacts of disease outbreaks on oyster production.  Several lines 
of evidence indicate that disease resistance is a heritable trait, at least for MSX.  For 
example, wild oyster populations growing in locations with a history of high MSX 
prevalence in the Chesapeake and Delaware Bays developed quantifiable levels of 
resistance to the disease in response to natural disease outbreaks (Haskin and Ford 
1979).   Selective breeding programs were established to build upon the naturally 
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acquired MSX resistance in oysters, and within a small number of successive 
generations, strains with high resistance were established (Ford and Haskin 1987).  
Selected, MSX-resistant lines demonstrate significantly higher survival compared to 
oyster populations with a history of no or limited exposure to the disease when both 
are deployed at locations with high disease pressure (reviewed in Carnegie and 
Burreson 2011). Although oyster strains have been observed to differ in their response 
to Dermo disease (Brown et al. 2005), their resistance level remain low compared to 
resistance to MSX (Powell et al. 2011). Powell et al. (2011) speculated on why the 
development of Dermo resistance had been slow. Oysters might have limited immune 
responses to the pathogen or development of Dermo resistance might be hindered by a 
rapidly changing virulence of its pathogen, P. marinus. Most importantly, Dermo 
mainly affects mature oysters that have passed one spawning cycle and the infection 
does not affect reproduction until it has reached lethal level. These factors make 
selection for Dermo resistance hard. Nevertheless, oysters with dual resistance to both 
Dermo and MSX are being developed (Calvo et al. 2003), since the parasites H. 
nelsoni and P. marinus often co-occur in the Atlantic Coast of the United States 
(Ewart and Ford 1993).   Currently, several oyster lines are available that have been 
selected for fast growth and disease resistance to a variety of diseases in various 
environmental conditions (Table 1).  
 
 
 
4 
 
Table 1. Examples of oyster lines/stocks developed through selective breeding 
for fast growth and resistance to a variety of diseases.  
Line Developed 
at  
Prevalent 
Environmenta
l Conditions at 
sites in which 
the selection 
was 
performed* 
Phenotype (disease 
resistance)  
Referenc
e  
UMFS 
(University 
of Maine 
Flowers 
Select) 
University 
of Maine 
Cold, high 
salinity 
Demonstrated high 
resistance to ROD; fast 
growth 
Barber et  
al. 1999 
Hawes et 
al. 1990  
Clinton Clinton, CT Warm, low-
high salinity 
Hypothesized resistance 
to MSX/Dermo/ROD 
based on disease levels at 
grow site and preliminary 
testing 
Sunila 
(pers. 
Comm.)  
NEH-RI Narraganset
t Bay, RI 
Warm, high 
salinity 
Developed using NEH 
oysters surviving an SSO 
outbreak in 2010-2011 
Gomez-
Chiarri et 
al. 
(unpub.)  
NEH Cape Shore, 
NJ 
Warm, medium 
salinity 
Demonstrated high 
resistance to MSX and 
moderate to Dermo 
Haskin 
and Ford, 
1979, Guo 
et al. 2003 
DEBY: 
(Delaware 
Bay)  
York River 
and 
Lynnhaven 
River, VA 
Warm, low-
high salinity 
Demonstrated high 
resistance to MSX and 
moderate to Dermo 
Calvo et 
al. 2003  
hANA: 
high-
salinity 
LouisiANA 
York River 
and 
Lynnhaven 
River, VA 
Warm, med-
high salinity 
Demonstrated moderate 
resistance to MSX and   
high resistance to Dermo 
ABC 
2009  
*Salinity range, low: 8-15 psu, medium: 17-25 psu, high: 28-35 psu; Temperature 
range, cold: average winter temperature < 3 ℃, warm: average winter 
temperature >3 ℃. 
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       Despite the aforementioned genetic improvements gained via selection, traditional 
methods of selective breeding have some limitations. First, these methods select for 
phenotypes (e.g. survival to disease outbreaks) instead of genotypes. However, 
survival is affected by many factors besides disease, such as temperature, salinity, and 
predation. Thus, the phenotype selected for might not indicate the presence of disease 
resistance. Secondly, the occurrence of disease is sporadic over space and time. Since 
it is very important for selective breeding to keep a constant selection pressure on the 
oyster populations, years with no disease pressure will have a negative impact on the 
selection process (Guo et al. 2008). Although traditional selective breeding methods 
through either mass or family selection are a powerful method for producing lines for 
the industry with certain desired phenotypes, a faster and more accurate way of 
selecting for disease resistance in oysters is needed. 
       Marker-assisted selection, whereby selection is imposed on genotype rather than 
phenotype, could enhance and accelerate the development of disease-resistant oyster 
lines (Lande and Thompson 1990). It identifies oysters with disease resistance based 
on genotypes by detecting markers associated with disease resistance. This approach 
allows the accurate identification of disease resistance in a species in the absence of 
disease pressure (Collard et al. 2005). In order to perform marker-assisted selection, 
breeders need genetic markers that have been confirmed to be associated with disease 
resistance in that species. 
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Association Studies for the Identification of Markers Associated with Particular 
Traits 
      Association studies are an effective approach to identify genetic markers 
associated with a certain trait, such as growth, shape, or disease resistance. It is 
particularly helpful for complex traits that are controlled by multiple genes, such as 
disease resistance in oysters (Ford and Haskin 1987).  Association studies utilize 
genetic markers and compare allele frequencies of these markers between two groups 
of organisms, one group with the trait of interest (case group) and one control group 
without the trait of interest (Cardon and Bell 2001).  If a significant difference in the 
genotype is consistently observed at a certain marker between the two groups, it 
indicates that the marker is closely located to a nearby genetic variant that is causing 
the difference or, less likely, is the direct genetic cause of the observed difference in 
phenotype (Hirschhorn et al. 2001).  Such studies have been commonly used to 
identify causes of diseases in humans (Hirschhorn et al. 2005, Oka et al. 1999) and 
economically important traits in agriculture, such as increased yield and disease 
resistance (Bai et al. 1999, Zhou et al. 2002, Brondani et al. 2002, Bermingham et al. 
2013, Zila et al. 2013). These studies usually are supported with genetic maps for the 
targeted species, so that the relative positions of markers on the chromosomes are 
known. It is worth noting that for the purpose of MAS, an available genetic map is not 
mandatory. Genetic markers with unknown locations on the chromosome can still be 
tested for association with the trait of interest, and once validated, can be used in MAS. 
But the availability of the genetic map of the targeted organism will be helpful in 
selecting genetic markers to make sure that they span the whole genome, ensuring 
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high coverage.  Furthermore, once a genetic marker detects a signal of difference 
between the control and case groups, a genetic map facilitates locating the genetic 
markers that have evidence of association on the chromosome and pin-pointing the 
functional genes through fine-scale mapping (Cardon and Bell 2001, Zhou et al. 2002).  
It has also been noted that the results of association studies often cannot be replicated 
by further studies, and that an association from a single report should not be trusted 
fully (Hirschhorn et al. 2005). Thus, verification of previous association study results 
in multiple populations is necessary. 
 
Marker Development in Eastern Oysters 
      Association studies required a large number of polymorphic markers (Liu and 
Cordes 2004). Recently, an increasing number of various types of genetic markers 
have been developed for eastern oysters, such as Amplified Fragment Length 
Polymorphism (AFLP) markers, microsatellites (MS), and Single Nucleotide 
Polymorphisms (SNPs). Over 200 AFLP markers were used in construction of the first 
genetic map for eastern oysters (Yu and Guo 2006).  AFLP markers are dominant and 
cannot be transferred among populations, which makes them less favorable than other 
co-dominant markers like microsatellites and SNPs, but they are still valuable for 
saturating linkage maps and increasing coverage (Guo et al. 2008). Over 300 
microsatellite markers have been generated in eastern oysters (Brown et al. 2000, 
Wang and Guo 2007, Wang et al. 2009, Reece et al. 2004). Many of the newly 
developed microsatellite markers were generated from ESTs (Expressed Sequence 
Tags), meaning that they are part of the coding sequence. More than 100 SNPs 
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markers have been generated from both ESTs and resequencing of functional genes 
with known or predicted functions. If association is detected using markers developed 
from coding sequences, there is a higher chance of detecting functional genes 
underlying the disease resistance trait, compared to an association detected at neutral 
loci (Liu and Cordes 2004).  
      Among these markers, microsatellite markers are particularly informative because 
they are highly polymorphic and are inherited in a co-dominant manner, meaning that 
heterozygotes can be identified (Wright and Bentzen, 1995). They have been used in 
association studies to identify markers associated with various traits in humans, plants 
and animals (Oka et al. 1999, McKnight et al. 2006, Zhou et al. 2002, Vigouroux et al. 
2002).  
 
Previous Association Studies on Disease Resistance in Eastern Oysters 
Successful association studies have been done to map disease resistance QTLs 
and to identify markers associated with disease resistance in eastern oysters (Yu and 
Guo 2006; Guo et al. 2008).  Several challenges to association studies for disease 
resistance in oysters exist.  First, it is hard to quantify the phenotype of disease 
resistance. The easiest evaluation of disease resistance in the field is survival. 
However, survival can be affected by factors other than disease, including 
environmental stress and predation.   Disease prevalence and intensity in the presence 
of disease pressure is a more specific indicator of disease resistance, but, it is 
expensive and, in some cases, oysters may be able to tolerate a high parasite load 
without obvious negative effects on survival or performance (Guo et al. 2008). 
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Secondly, there is a lack of well-characterized highly-inbred susceptible and resistant 
oyster lines. As a result, the usual control-case association study design cannot be 
directly implemented, since there are no obvious candidates for the control groups and 
case groups. To overcome this challenge, another approach has been used in oysters, 
in which control and case oysters are taken from a single population but at different 
times regarding the disease outbreaks. The control group consists of oysters randomly 
sampled from the population before a mortality event caused by diseases, usually at 
the beginning of the summer. The case group consists of oysters randomly sampled 
from the population right after a mortality event, as these survivors are likely to be 
resistant to diseases. The two groups of oysters are then sacrificed and genotypes are 
then compared. Markers that show significant allele distribution shifts between the 
two groups are thought to be linked to disease response. If affected markers are 
clustered close on the genetic map and have shifts in the same direction, the region 
containing these markers is identified as a QTL (quantitative trait loci) for disease 
resistance. In order to facilitate mapping these QTLs, oyster families (instead of oyster 
populations) were used in these association studies (reviewed in Guo et al. 2008).  
      The results from these family-based association studies in oysters are summarized 
in Figure 1. The first map (Figure 1a) summarizes the results from several association 
studies for resistance to Dermo disease, as evaluated through allele frequency shifts 
after a Dermo disease-related mortality event in the field (reviewed in Guo et al. 2008). 
This map includes 313 markers (249 AFLPs, 47 MS, and 17 SNPs), resulting in a total 
genetic length of 729.9 cM. The average interval between markers is 2.3 cM. The map 
describes the location of 47 functional genes or expressed sequences. Based on results 
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from previous association studies, 26 AFLP markers, 1 SNP, and 6 microsatellite 
markers had significant after-mortality frequency shifts. After mapping these markers 
on a linkage map, regions containing 2 or more markers with frequency shifts in the 
same direction were used to identify 8 QTL regions potentially associated with disease 
resistance (Figure 1a; Guo et al. 2008). The 6 microsatellite markers showing 
significant post-mortality shifts and clustered in QTL regions were RUCV 97, RUCV 
58, Cv02i23, Cvi2j24, Cvi2i4, and Cvi1g4.  
       In an unpublished study performed in 2010, Zhang, Guo, and Gomez-Chiarri used 
the same association study strategy to identify genetic markers associated with ROD-
resistance. Two oyster families with differences in susceptibility to ROD were used. In 
order to minimize the impact of field environmental conditions on survival, the oysters 
were challenged with cultured Roseovarius crassostreae, the causative agent of ROD, 
in laboratory conditions. The study tested 257 genetic markers (90 MS, 2 SNP, and 
155 AFLP markers). Twenty-eight markers (11 MS, 1 SNP and 16 AFLP markers) 
were identified to experience significant post-mortality frequency shifts and 22 of 
them were mapped (Zhang, Guo, and Gomez-Chiarri unpublished, Figure 1b). Two 
microsatellite markers that had significant post-mortality shifts and are publicly 
available are RUCV 66 and Cvi2m10. We also decided to include it in this study 
RUCV 270, a marker in linkage group 10 located in relative proximity to another 
marker (Cvi12) for which a significant shift was detected after ROD mortality.   
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Figure 1. Two genetic maps used to select microsatellite markers for this study. (a) A 
modified version of the genetic map by Guo et al. (2008). In red are microsatellite or 
SNP markers, in black are AFLP markers. Markers in bold showed significant shifts 
in frequency after disease-related mortalities. Lines encompassing regions within 
selected linkage groups indicate disease resistance QTLs. In black boxes are the 
candidate markers selected for this study. (b) Genetic map with genetic markers 
showing shifts in frequency after an ROD experimental challenge (Zhang, Guo, and 
Gomez-Chiarri, unpublished). Markers in red were genetic markers showing 
association with resistance to ROD. Markers in black boxes were candidate markers 
investigated in this study.  
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Goal of this Project 
      Previous family-based association studies have identified several markers 
(including 8 publically available microsatellites) associated with disease resistance in 
oysters (reviewed in Guo et al. 2008).  However, due to families’ low genetic diversity, 
a family-based approach might not truthfully reflect wild population situations. Thus, 
results obtained from family-based studies should be further confirmed by subsequent 
studies using multiple oyster lines (mixed families) or cultures stocks and ultimately in 
wild oyster populations.  
This project aimed to verify 8 several previously identified microsatellite 
markers that had evidence of association to disease resistance in oysters, and to 
possibly identify new associated markers by testing 12 additional microsatellite 
markers without previous evidence of association using samples from an oyster stock 
deployed in two separate field locations that experienced mortality due to Dermo and 
MSX collected by a previous field performance study (Proestou et al. in preparation). 
Oysters before and after the disease-caused mortality event were genotyped at the 20 
genetic marker loci. Significant post-selection allele distribution shifts, supported fully 
or in part by other lines of evidence (consistent shifts in allele frequency in the same 
direction at the 2 different sites and/or mapping of these markers to disease resistant 
QTLs in other studies), were considered as evidence for potential association with 
disease resistance.  
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METHODS 
Oyster Samples  
Oysters samples were available from a previous study that evaluated the 
performance of 6 oyster lines or stocks in 5 locations in the East Coast of the US 
(Proestou et al. in preparation). Samples of oysters (between 30 and 60) from each of 
the lines/stocks at each of the sites were collected at deployment (August 2012) and in 
Spring (March or April, depending on the site), Summer (August/September) and Fall 
(October/November) of 2013.  NEH-RI oysters (derived from brood stock oysters 
from the NEH line deployed in Rhode Island that survived an SSO outbreak) deployed 
in August 2012 at two locations (Cape Shore, NJ and York River, VA) were used for 
this study, because of the high disease-related mortality (more than 30%) that these 
oysters experienced 1 year after deployment at both sites during the period spanning 
the summer and early fall (July – September 2013, Supplementary Figures 1 and 2).  
Mortality in this period was attributed to MSX and/or Dermo diseases based on high 
prevalence and intensity of the parasites P. marinus and H. nelsoni in oysters collected 
in September 2013 (as determined by quantitative real time PCR; qPCR; 
Supplementary Table 1; Proestou et al. unpublished).   
 
DNA Extraction and Evaluation 
       Oysters were shucked, and tissue samples from mantles and gills were stored in 
70% ethanol at -20 degrees Celsius until extraction. Genomic DNA was extracted 
from mantle and gill tissues using either a Chelex method (Aranishi and Okimoto 
2006) or Autogen’s Quickgene Mini80 system (Autogen Inc., Holliston, MA; Pereira 
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et al. 2011). The Chelex method has the advantage of being fast and inexpensive, but 
the DNA extracted was fragmented to ~500bp fragments, which reduces the success of 
PCR amplification for genetic markers of longer fragment. Therefore, the Autogen 
method was used later in the study, for it yielded higher quality DNA. The change of 
extraction method should not affect the integrity of the data since the same genotypes 
were obtained from successful PCR amplification of DNA from tissues of selected 
individual oysters that was extracted using both methods (data not shown). DNA 
quantity and quality were evaluated using a NanoDrop 8000 instrument (Thermo 
Fisher Scientific Inc., Waltham, MA).  DNA was diluted to 7.5-10 ng/ul for PCR 
amplification. DNA was stored at -20˚C until use.   
 
Microsatellite Marker Selection 
      Twenty previously published microsatellite markers were used to genotype the 
control and selected populations (Reece et al. 2004, Wang and Guo 2007, Wang et al. 
2009).  These markers were chosen based on allele size range and ability to multiplex, 
level of polymorphism, and reported frequency of null alleles and are therefore 
appropriate for detecting genetic differentiation among oyster populations.  Moreover, 
9 of the 20 loci included in this study were located within previously defined disease 
resistance QTL or near (RUCV 270) a marker showing a significant shift in allele 
frequency after ROD mortality (Table 2, Guo et al. 2008, Guo, Zhang, and Gomez-
Chiarri, unpublished). The 5’end of the forward primer from each locus was labeled 
with one of four fluorescent dyes (PET, NED, 6-FAM and VIC) and markers were 
assigned to one of five plexes, based on allele size range and dye color (Table 2). 
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Table 2. Microsatellite markers used in this project. Markers shaded grey represent 
those located within disease-resistance QTLs. *Marker located near a marker showing 
a significant shift in allele frequency after a mortality event (Guo et al. 2008, Guo, 
Zhang, and Gomez-Chiarri, unpublished). 
 
Plex Name Ta MgCl2 
(mM) 
Direction Primer Sequence Reference 
A 
RUCV 1 60 1.5 fwd AGTCAAGAACTATACAAATTTACGCT Wang and Guo 2007 
   rev CTCACAGACCATGAAAATGGGCTGTT  
RUCV 3 60 1.5 fwd AGTTATCCATTCTGTTGTGGAAGTGA Wang and Guo 2007 
   rev GTTTGTCCCGACAACATACCGCCATT  
RUCV 46 60 1.5 fwd GTCGTGCAAGTTGACATTCC Wang and Guo 2007 
   rev TCCACCTCTATTTCATGTTGTCC  
RUCY 28 55 1.5 fwd GGAGGCCCAAGAACTGCGAGGGGACC Wang and Guo 2007 
   rev TTGAAAACATGCACGTCCGGCAACAT  
D 
RUCV 11 60 1.5 fwd TGCCGGTCGTTCTTTCAGGTATGTTC Wang and Guo 2007 
   rev TTTCTGAAGGGACACTGATAGTGAGT  
RUCV 27 60 1.5 fwd GCTGATCGGGATGGCGAGAGAGTGAC Wang and Guo 2007 
   rev TGAAAACATGCACGTCCGGACAACAT  
Cv02i23 51.5 1.5 fwd TAACACAAAGCCAACATCGCC Reece et al. 2004 
   rev AAGTAAAAGACGGTCAAAGGGTCC  
RUCV 66 60 1.5 fwd ACCATCAGCAACACAGAACG Wang and Guo 2007 
   rev GGGTCCCAAGTGTTGTCG  
E 
RUCV 24 55 1.5 fwd AAAAGGGAATTTTGTTACACAATCCA Wang and Guo 2007 
   rev AAAAACAAAATAATGAATACATTGGC  
RUCV 97 55 1.5 fwd AGCCATGATTGAGGAATTGG Wang and Guo 2007 
   rev ATCCCCTAAAGTGCGACTGG  
RUCV 68 60 1.5 fwd TCTTGGAATGACAAGCAAGC Wang and Guo 2007 
   rev CCAGGGGTCAACAGTTTCC  
Cvi2j24 53 1.5 fwd CGTAGCCAGAAGGGGGGTTTC Reece et al. 2004 
   rev GCAGTGAGACACGATAAAAGAAGCC  
F 
RUCV 23 55 1.5 fwd GCAAGATGGGGATGATCAACCTGCAT Wang and Guo 2007 
   rev GGACATCGGATCCCAGTGTCGGTTGA  
Cvi2i4 46 1.5 fwd AATAATACAAAATCCAGTAGC Reece et al. 2004 
   rev CCAATCAAATCTCACTAAAG  
RUCV 18 60 1.5 fwd TACTTTAATTGCATGCATGTGGTTGT Wang and Guo 2007 
   rev GTCGGTCTGCTTGATCTGTGAAGGTT  
RUCV 270* 60 1.5 fwd GGACCAAATATTCCACATCACAC Wang et al. 2009 
   rev AAGCTGAATGCCCAAACATC  
G 
RUCV58 60 2.5 fwd TTGGAATTTTAATAAATGTCAGAAAGG Wang and Guo 2007 
   rev AACTTAGTTAACATTTTGGAATTGG  
Cvi1g4 50 1.5 fwd TCATAAACAATCAGTGACACAG Reece et al. 2004 
   rev GCAAAGTAAGGGGTAAGATG  
Cvi1g3 51 1.5 fwd CATAAAGTTAATGCTTC Reece et al. 2004 
   rev ATAGCGAGTTGAGGAACC  
Cvi2m10 50 2 fwd CGAATCTGTGTTGATGAAAGG Reece et al. 2004 
   rev CCATGTCTCTCATCGTCAGTGCC  
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PCR Amplification and Genotyping 
      DNA from each oyster was amplified using PCR for each microsatellite marker 
individually and then the amplification products for 4 microsatellites were multiplexed 
for genotyping. PCR reactions were run in a 10-µl solution containing 1X PCR Buffer 
with 1.5-2.5mM MgCl2, 0.2mM dNTPs, 0.5 U of Qiagen’s Toptaq DNA polymerase, 
0.3 µM of each primer and 10-15 ng of oyster genomic DNA (Qiagen’s TopTaq 
Polymerase Kit; Qiagen, Hilden, Germany).  PCR for all but three markers (RUCV 58, 
Cvi2m10, Cvi2i4) was carried out using a touchdown PCR protocol (used to increase 
specificity and sensitivity of amplification; Korbie and Mattick 2008)  as follows: 94℃ 
for 3 minutes, 10 cycles of 94℃ for 30s, 5℃ above annealing temperature (Ta) of the 
marker for 30s (decrease 0.5℃ every cycle), 72℃ for 30s, followed by 25 cycles of 94℃ 
for 30s, annealing temperature (Ta) for 30s and 72℃ for 30s, and a final extension at 
72℃ for 30 min (Jaris 2014). Cvi2i4, RUCV 58, and Cvi2m10 were amplified as 
previously described (Reece et al. 2004, Wang and Guo 2007). RUCV 58 and 
Cvi2m10 required 2.5mM and 2mM MgCl2 respectively for successful amplification. 
Gel electrophoresis was used to confirm successful amplification using 2% agarose gel.  
For each individual oyster sample, PCR products from the four loci belonging to a 
particular plex were pooled in equimolar amounts and purified with the Agencourt 
AMPure XP system (Beckman Coulter Inc., Brea, CA) according to the 
manufacturer’s protocol.  Purified pooled PCR products were sent to Yale DNA 
Analysis Facility for fragment analysis. Genotypes were called with GeneMarker 
software (SoftGenetics LLC., State College, PA), and subsequent manual editing. 
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Allele binning was conducted using Allelogram software (Morin et al. 2009), where 
the length of the repeat motif for each marker provided a guideline for bin size. 
 
 
Data Analysis 
Population multi-locus pairwise FST  (an index between 0 – 1 that estimates the 
degree of genetic differentiation between oyster populations at each of sampling time 
points, with 0 indicating no differentiation; Wright 1978) was calculated to determine 
population structure within the NEH-RI stock in each site between each of the 
sampling time points. Arlequin software ver 3.5 was used to conduct data analysis 
(Excoffier and Lischer 2010). Data from the allele binning needed to be formatted for 
Arlequin software to recognize and process. The format conversions, along with the 
generation of allele frequency data was done by the software CONVERT (Glaubitz).  
The FST  calculation was done through the “Population comparisons” function in 
Arlequin. Number of permutations was set to 3000 with a significance level (p) of 
0.05. Arlequin was set to tolerate 15% of missing data. Locus-by-locus AMOVA was 
also conducted to calculate the FST value for each locus, in order to determine which 
loci may be under selection during the mortality event.  
The statistical analysis package R (R Development Core Team 2008) was used to 
perform Fishers’ exact test on allele count data to determine the probability of whether 
allele distributions of pre- and post-selection samples within each of the sites were 
different.  Fisher’s exact test was chosen over the chi-square test because of the small 
sample size (McDonald 2014). The p-value  returned from Fisher’s exact test was 
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corrected (Pc) by multiplying by the number of alleles for each marker, in order to 
compensate for multiple comparisons (Oka et al. 1999).  Markers that showed 
significant shifts in both sites and markers that had significant shift in one site but 
were previously known to be in disease resistance QTLs were considered to be 
markers of interest.   
In order to find out whether affected markers were related to known functional 
genes related to host-defense, translated protein (tblastx) and nucleotide (blastn) blast 
(Stephen et al. 1997) were used to conduct homology searches in the NCBI server. 
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RESULTS 
 
Amplification and Genotyping 
All 20 microsatellite markers were successfully amplified in most samples, with 
some samples that failed to amplify for one or more marker loci due to low DNA 
quality or errors in carrying out PCR. In order to reduce the amount of missing data, 
samples with failed amplifications for five or more ( 25% of total markers) markers 
were discarded (Table 3).  
 
Table 3. Number of samples used in statistical analyses after discarding samples 
with five or more unsuccessful amplifications. 
 
Time point 
Number of samples retained for 
further analysis 
Number of total 
samples before 
discarding 
Number of discarded 
(Percent) 
Virginia    
Aug-2012 40 47 7 (15%) 
Mar-2013 28 30 2 (7%) 
Aug-2013 31 32 1 (3%) 
Sep-2013 57 58 1 (2%) 
Oct-2013 36 47 11 (23%) 
New Jersey    
Apr-2013 47 47 0 (0) 
Nov-2013 48 48 0 (0) 
 
Determination of Pre- and Post-selection Time Points for the Association Study 
For this association study, the control population will be oysters before selection by 
disease and the case (selected) population will be oysters after selection by disease. At 
the Cape Shore, NJ site, August 2012 and March 2013 sample collections were both 
considered as possible candidates for the control, unselected population given that 
very little mortality was observed during that time period (Supplementary Figure 2).  
In contrast, significant overwinter mortality (~50%) was observed at York River, 
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Virginia between August 2012 and March 2013, making the August 2012 sampling a 
less viable candidate for the control population at that site, since the use of this sample 
as a control would not allow to differentiate between disease-related mortality and 
over-winter mortality.   However, the March 2013 collection from York River, VA 
contained only 30 individuals (Table 3), which is a relatively small sample size for 
detecting significant allele frequency shifts. Population pairwise multi-locus FST  
between samples collected at different time points after deployment at the Virginia site 
were calculated using the set of 20 markers to determine the effect of mortality on 
population structure in samples from selected time points (Table 4).  The FST  value 
between the Aug-12 and Mar-13 samples (spanning over-winter mortality; FST  = 
0.01511, p= 0.05025 was almost the same as the FST  value between Mar-13 and Oct-
13 (spanning disease-related mortality; FST  =0.0148, p= 0.06413), suggesting that the 
over-wintering mortality posed a selection on the oysters that is comparable in 
strength to the selection from disease-related mortality. Thus, Mar-13 was chosen as 
the sole pre-selection time point (control group), despite of the low sample size (n=30), 
while Oct-13 was chosen as the post-selection time point (case group).  The equivalent 
time points (Apr-13 and Nov-13) were chosen as control and case groups for oysters 
deployed in New Jersey (pairwise multi-locus FST  = 0.0244, p = 0.0003). 
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Table 4. Population multi-locus pairwise FST  for oyster samples collected at 
different time points after deployment in the Virginia site. Numbers in bold are 
statistically significant (p-value<0.05).  
 Aug-12 Mar-13 Aug-13 Sep-13 Oct-13 
Aug-12 0     
Mar-13 0.01511 0    
Aug-13 0.00505 0.00972 0   
Sep-13 0.01012 0.00858 0.00013 0  
Oct-13 0.01887 0.0148 0.00693 0.0072 0 
 
 
Identifying Markers Showing Allele Frequency Shifts after a Disease-related 
Mortality Event 
     Fisher’s exact test was conducted comparing the allelic distributions between pre- 
and post-selection time points. In the samples collected in Virginia, 3 out of 20 
markers had significantly different allelic distributions between the pre and post-
disease-related mortality event, while 9 out of 20 were significantly different in 
oysters collected in New Jersey (Table 5).  Two markers (RUCV 68 and RUCV 270) 
had significant shifts in allele distributions in both sites, suggesting similar selection 
forces (probably mortality due to Dermo and MSX diseases, based on disease 
prevalence and intensity, supplementary Table 1) at the 2 sites. Two other markers 
(RUCV 97 and Cv02i23) with previous evidence of association had significant 
different allele distribution between pre- and post-disease-related mortality event in 
one of the two sites only. Interestingly, several markers without previous evidence 
association also detected a significant shift in allelic distributions (Table 5). Locus-by-
locus AMOVA results agreed closely with the Fisher’s exact test results in the New 
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Jersey site. Both tests detected statistically significant differences in genotypes for the 
same loci in pre- and post-mortality populations, with the exception of RUCV1 and 
Cvi02i23 (which were significant by the Fisher’s exact test, but showed no significant 
FST ) and Cvi2j24 (which was significant by FST   but not the Fisher’s test)  
(Supplementary Table 2). The locus-by-locus AMOVA did not yield the same markers 
that had significantly different allele distribution as the Fisher’s exact test for the 
Virginia samples, with only two markers showing significant FST values (RUCV 46 
and Cvi2m10). However, looking at FST values alone, markers that were detected as 
significant in the Fisher’s exact tests in Virginia samples (RUCV 68 and RUCV 270) 
showed FST values on the higher part of the range (between -0.010 and 0.33) for 
samples in this site.  
Table 5. Markers showing a significant shift in allele distribution between samples 
collected pre- and post-disease-related mortality event as detected using the Fisher’s 
exact test (Pc<0.01, Pc is the P value after correction by multiplying it by the number 
of alleles for each marker). Markers with a dash showed no significant shifts. Markers 
in bold or marked with a (*) mapped to disease-resistant QTLs or were near a marker 
showing a significant shift in allele frequency post mortality in previous studies. LG: 
Linkage group. 
 
 
PLEX Marker (Linkage Group according to Guo 
et al. 2008) 
York River, 
Virginia 
Cape Shore, New 
Jersey 
A RUCV 1  - 0.0000642 
RUCV 3  - 0.000422 
RUCV 46  -  - 
RUCY 28  - 0.0000696 
D RUCV 11  - 0.00144 
RUCV 27  - 0.000138 
Cv02i23 (LG2)  - 0.000081 
RUCV 66  -  - 
E RUCV 24  -  - 
RUCV 97 (LG2)  - 0.0000341 
RUCV 68 0.00169 0.0000376 
Cvi2j24 (LG2)  -  - 
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F RUCV 23  -  - 
Cvi2i4 (LG2)  -  - 
RUCV 18  - - 
RUCV 270* 0.0038 0.0000944 
G RUCV58 (LG2)  -  - 
Cvi1g4 (LG9)  -  - 
Cvi1g3 0.00411  - 
Cvi2m10 (LG6)  -  - 
 
     In order to minimize the detection of false-positives and to provide additional 
support for detected associations, a closer inspection of the allele frequency shifts was 
conducted for those markers that showed significantly different allelic distribution in 
either one or both sites. Markers that shifted in frequency in the same direction in both 
sites, suggesting a response to a similar selection force (the disease-related mortality 
event), were of particular interest.  For each marker, the allele showing the highest 
shift in the same direction in allele frequency in both sites was tested using the 
Fisher’s exact test to determine the significance of the shift.   Alleles showing 
significant shifts in allele frequency pre and post-disease-related mortality in the same 
direction in both sites included RUCV 270 (allele 545) and RUCV 27 (203), while the 
allele frequency shift in RUCV 28 (228), RUCV 97 (271) and RUCV 3 (292) was 
only significant in the New Jersey site. Cvi1g3 (240) was only significant in the 
Virginia site.  
 
 
 
 
 
 
Table 6. Allele frequency for markers that had significantly different allelic 
distribution between pre- and post-disease-related mortality. Shading indicates the 
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allele with the highest frequency shift in the same direction in samples from both sites. 
* indicates statistical significance (Fisher’s exact test, p-value<0.05). 
  
Virginia New Jersey 
Marker Allele 
Pre-
selection 
frequency 
Post-
selection 
frequency 
Change 
Pre-
selection 
frequency 
Post-
selection 
frequency 
Change 
RUCV 
28 
222 0% 0% 0% 2% 2% 0% 
224 2% 13% 11% 3% 0% -3% 
226 2% 5% 3% 7% 15% 8% 
228 21% 10% -11% 16% 0% -16%* 
232 13% 19% 7% 25% 19% -6% 
234 8% 13% 5% 0% 4% 4% 
236 0% 0% 0% 4% 6% 2% 
238 19% 11% -7% 14% 34% 20% 
240 13% 15% 2% 2% 4% 2% 
242 4% 10% 6% 9% 5% -4% 
244 17% 5% -12% 15% 8% -7% 
248 0% 0% 0% 2% 2% 0% 
250 2% 0% -2% 0% 0% 0% 
RUCV 3 
284 35% 35% 0% 43% 26% -18% 
288 9% 9% 0% 9% 2% -7% 
292 31% 46% 14% 28% 60% 31%* 
296 2% 0% -2% 7% 6% 0% 
300 20% 10% -10% 11% 4% -7% 
308 2% 0% -2% 2% 2% 0% 
RUCV 
27 
197 4% 12% 8% 2% 2% 0% 
199 2% 6% 4% 2% 1% -1% 
201 0% 3% 3% 9% 15% 6% 
203 29% 10% -18%* 16% 0% -16%* 
205 0% 0% 0% 0% 2% 2% 
207 21% 38% 17% 26% 21% -5% 
209 0% 0% 0% 2% 4% 2% 
211 7% 0% -7% 2% 6% 4% 
213 23% 26% 3% 17% 38% 20% 
215 0% 3% 3% 5% 2% -3% 
217 7% 1% -6% 5% 5% 0% 
219 4% 0% -4% 12% 2% -10% 
223 4% 0% -4% 2% 2% 0% 
RUCV 
68 
321 0% 0% 0% 0% 1% 1% 
327 56% 54% -1% 20% 38% 18% 
330 17% 1% -15% 17% 24% 8% 
333 0% 7% 7% 0% 8% 8% 
336 0% 1% 1% 0% 0% 0% 
339 28% 36% 8% 63% 29% -34% 
RUCV 
18 
135 6% 4% -1% 4% 6% 2% 
137 37% 26% -11% 29% 49% 20% 
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139 56% 65% 10% 64% 37% -27% 
141 2% 4% 2% 3% 7% 4% 
RUCV 
270 
529 4% 3% -1% 0% 11% 11% 
545 0% 13% 13%* 5% 21% 17%* 
549 18% 8% -10% 2% 2% 0% 
553 6% 11% 5% 5% 0% -5% 
561 0% 3% 3% 1% 4% 3% 
565 4% 0% -4% 0% 0% 0% 
569 30% 40% 10% 60% 41% -19% 
577 14% 2% -12% 15% 7% -7% 
581 24% 19% -5% 13% 13% 0% 
Cv02i23 
359 2% 0% -2% 4% 1% -3% 
363 25% 36% 11% 28% 19% -9% 
371 14% 17% 2% 15% 5% -10% 
375 45% 40% -4% 46% 47% 1% 
379 4% 3% -1% 0% 17% 17% 
387 0% 1% 1% 0% 0% 0% 
403 2% 0% -2% 2% 4% 2% 
451 0% 0% 0% 1% 0% -1% 
459 0% 1% 1% 0% 0% 0% 
463 0% 0% 0% 1% 5% 4% 
475 4% 1% -2% 3% 0% -3% 
479 5% 0% -5% 0% 1% 1% 
483 0% 0% 0% 0% 1% 1% 
RUCV97 
245 13% 9% -4% 6% 12% 6% 
247 6% 1% -4% 5% 2% -3% 
249 0% 0% 0% 0% 1% 1% 
251 0% 1% 1% 5% 2% -3% 
253 4% 1% -2% 4% 1% -3% 
255 9% 12% 3% 14% 13% -1% 
257 17% 3% -14% 9% 8% -1% 
259 28% 32% 5% 24% 24% 0% 
261 9% 7% -2% 7% 0% -7% 
263 2% 6% 4% 11% 5% -6% 
267 4% 3% -1% 3% 10% 7% 
269 2% 0% -2% 0% 1% 1% 
271 0% 3% 3% 0% 13% 13%* 
275 4% 3% -1% 1% 0% -1% 
277 4% 12% 8% 7% 0% -7% 
287 0% 3% 3% 2% 8% 6% 
319 0% 3% 3% 0% 0% 0% 
Cvi1g3 
240 17% 0% -17%* 2% 0% -2% 
246 0% 1% 1% 6% 0% -6% 
255 4% 3% -1% 5% 10% 5% 
258 50% 63% 13% 59% 55% -4% 
261 2% 0% -2% 0% 4% 4% 
264 27% 33% 6% 28% 31% 3% 
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Homology Search 
    As all RUCV markers were developed from coding sequences (ESTs), there is a 
chance that they are part of the functional genes. A homology search with tblastx in 
the non-redundant database (Stephen et al. 1997) was conducted for markers that 
showed significant shift in allelic distribution in either one site or two sites. Nucleotide 
blast was also conducted for markers that did not detect a hit initially with tblastx. 
RUCV 68 was found to be homologous to the 40S ribosomal protein S28 (Table 7). 
RUCV 27 and RUCV 28 showed identity with a predicted cell-number regulator 3-
like protein that contained a PLAC8 (Placenta-specific 8) domain in the closely related 
species C. gigas. Cv02i23 found was found to be homologous to another hypothetical 
protein in C. gigas, but tblastx did not detect any putative conserved domains (Table 
7).  
Table 7. Results of homology search for markers that showed significant shift 
in allelic distributions in at least one site. In bold or marked with a (*) mapped 
to disease-resistant QTLs or were near a marker showing a significant shift in 
allele frequency post mortality (*) in previous studies.  
Marker Accession 
number 
Query 
length 
 EST homology Domain E-
value 
Query 
cover 
Identity 
RUCV 68 gi|31908118 720  40S ribosomal 
protein S28 
[Crassostrea 
gigas] 
S1_S28E 3e-23 20% 100% 
RUCV 270* gi|31902968 841  No hit - - - - 
RUCV 97 gi|14581013 687  No hit - - - - 
Cvi1g3 gi|49618833 
 
218  No hit - - - - 
Cv02i23 gi|49618841 
 
331  Hypothetical 
protein 
CGI10008026 
[Crassostrea 
gigas] 
- 8e-16 70% 69% 
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DISCUSSION 
RUCV 3 gi|31908953 903  No hit - - - - 
RUCV 28 gi|14581194 622  Predicted: cell 
number regulator 
3-like 
[Crassostrea 
gigas] 
PLAC8 1e-54 52% 94% 
RUCV 27 gi|14581203 607   Predicted: cell 
number regulator 
3-like 
[Crassostrea 
gigas]] 
PLAC8 1e-64 53% 92% 
RUCV 1 gi|39726421 305  No hit - - - - 
RUCV 11 gi|31906314 791  No hit - - - - 
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The aim of this study was to gather new or strengthen existing evidence 
supporting the association of previously published markers with disease-resistant 
phenotypes as performed in family-based studies by determining if these markers also 
experience a significant shift in allele frequency in an oyster stock experiencing 
Dermo and MSX-related mortality in 2 different sites.   Among our panel of 20 
microsatellites, it was expected that the 8 markers located in regions previously 
associated with disease resistance (Guo et al. 2008, Zhang, Guo and Gomez-Chiarri, 
unpublished) would have a higher probability of discriminating among populations 
pre- and post- a disease-related mortality event.  However, none of these markers 
showed significant differentiation in allelic distribution before and after mortality at 
both the Virginia and New Jersey deployment sites. Of these 8 markers, only 2 could 
differentiate between populations pre- and post- the disease-related mortality event at 
one of the two sites (Cv02i23 and RUCV 97-New Jersey). Interestingly, a signal of 
potential selection was detected at two markers (RUCV 270 and RUCV 68) with no 
expectation of association with disease at both deployment sites and several markers 
(RUCV1, RUCV3, RUCV11, RUCV18, RUCV27, and RUCV28) at the New Jersey 
site.  
In our study, RUCV 270 was the strongest candidate to have association with 
Dermo and MSX disease resistance in eastern oysters, since it showed a significant 
post-mortality shift in allelic distribution in the same direction in both sites. Allele 545 
of RUCV 270 was particularly interesting, since it increased significantly in both 
populations after the mortality event, suggesting that it was under selection during this 
event. The EST sequence from which RUCV 270 is derived was not homologous to 
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any sequences in the non-redundant nucleotide database based on tblastx search, 
suggesting that the EST sequence containing RUCV 270 does not code for known 
proteins. This is not unexpected since many microsatellite markers do not code for 
proteins, but they may experience shifts in allelic distribution in response to a disease-
related mortality event because the functional genes under selection are nearby on the 
chromosome. RUCV 270 mapped to linkage group 10 (Guo et al. 2008) and there are 
8 other genetic markers (2 MS and 7 AFLP markers) within 5cM of RUCV 270 
(Zhang, Guo and Gomez-Chiarri, unpublished). However, none of these markers 
showed significant shifts in allele frequency after ROD mortality except Cvi12, the 
one closest to RUCV270 according to the genetic map (Figure 1).  The next logical 
step is to fine-map this region and test more genetic markers in the close vicinity of 
RUCV 270 and Cvi12 for association with disease resistance, in order to determine if 
this is a disease-resistant QTL and ultimately identify the functional gene under 
selection.   
Results of the Fisher’s exact test suggested a high probability that allelic 
distribution at marker RUCV 68 was different before and after selection in both sites.  
However, closer examination of individual allele frequency shifts at this marker show 
no significant shifts in the same direction at the two deployment sites. The mostly 
differing response to selection of this alleles at the two deployment sites does not 
support an association of this marker with disease resistance.  
Several of the markers used in this study were located in a region of linkage 
group 2 associated with disease-resistance that also contains the serine protease gene, 
a functional gene that has been associated with disease resistance (Guo et al. 2008). 
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Serine protease inhibitors have demonstrated ability to inhibit the proliferation of the 
Dermo pathogen, Perkinsus marinus (La Peyre et al. 2010). A polymorphism in the 
serine protease inhibitor promoter region has been shown to be associated with 
resistance to Dermo, and was verified comparing susceptible and resistant oyster lines 
(Yu et al. 2011, He et al. 2012). Of the 5 markers in linkage group 2 tested in this 
study, only Cv02i23 and RUCV 97, showed significant shifts in allele frequency after 
the mortality event in our study, and in only one of the sites (New Jersey). A lack of 
detection of a significant association with disease resistance may be due to the 
limitations of our study, including a small sample size, especially for the Virginia site 
(28 pre-selection samples and 36 post-selection samples), which would limit the 
power to detect noticeable post-mortality shifts. The Virginia site also experienced 
high over-wintering mortality (over 50%), and the fact that pre-winter samples have 
significantly differentiated genetic composition suggests that over-wintering already 
had a selection effect on the oysters. If the alleles associated with disease resistance 
were reduced to a low level by over-wintering selection, it would reduce our ability to 
detect them by analyzing post-mortality allele frequency shifts. More significant post-
mortality shifts in oyster samples from New Jersey site were detected, which could be 
explained by the larger sample size and low over-wintering mortality. Moreover, using 
highly polymorphic microsatellite markers proved to be a bit problematic, as sample 
sizes allocated for each allele can be extremely small. Their favorably high variability 
needs to be backed up with a large sample size. In future studies, SNPs might be better 
candidates if a large sample size is not available. It would be interesting to genotype 
the polymorphism in the serine protease inhibitor gene of our samples to determine 
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whether it was associated with better survival and whether its change in allele 
frequency is in accordance with those detected for Cv02i23 or RUCV97.  
Five other markers without previous evidence of association showed significant 
allelic distribution shift in one site in our study. We cannot confidently say that these 
markers are associated with disease resistance, and more association study needs to be 
done for these markers. However, RUCV 3 in this group had the largest allele 
frequency shift in the same direction of all the affected markers, although no 
statistically significant allelic distribution shift was detected in the Virginia site. 
RUCV 27 and RUCV 28 matched to the same gene, and both showed allele frequency 
shift of more than 10% in the same direction in both sites, which indicated that they 
could be under selection. These 2 markers showed homology to a predicted cell-
number-regulator-like protein in C. gigas that contains a PLAC8 domain, a cysteine-
rich domain found in a variety of proteins in animals, plants, fungi and algae (Song et 
al. 2011). The study of PLAC8 containing proteins only started recently and variety of 
functions have been proposed or observed, including controlling fruit size, cell number, 
and heavy metal transport in plants (Song et al. 2011). Association studies with more 
populations need to be done to confirm whether RUCV 27 and RUCV 28 are 
associated with disease resistance, and investigate the potential functional role in 
disease resistance of PLAC8-containing proteins. 
Marker-assisted selection in oysters is still in its very early stage. The main 
challenge is the lack of validated genetic markers associated with disease resistance. 
This study provides extra support for several candidate markers of disease-resistant 
markers identified by previous studies. The scientific community should prioritize 
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these markers in further investigations, with a particular focus on fine mapping the 
QTL in linkage group 2 and determining if a disease resistant QTL could be present in 
linkage group 10.   
 
 
 
  
34 
 
APPENDIX 
Field Evaluation of Disease Resistance in Oyster Lines. 
     Our study took advantage of samples collected from a previous unpublished 
collaborative study funded by the Agricultural Research Service (ARS) was done to 
evaluate the performance of six lines (Table 1) of oysters deployed at five different 
locations along the east coast from September 2012 to November 2013 (Damariscotta 
River, Maine, Narragansett Bay and Ninigret Pond in Rhode Island, Cape Shore, New 
Jersey and York River, Virginia). Growth and survival were measured for 16 months 
and samples were collected in cases of high-mortality events for disease diagnosis and 
future genotyping. Strong genotype by environment interactions were observed: 
oysters from three of the northern lines (UMaine, NEH-RI, and Clinton) were 
significantly larger and had significantly higher survival rates than the southern lines 
(hANA and DEBY) in the Rhode Island sites, while the southern lines had a higher 
yield than the northern lines in the Delaware and Chesapeake Bay sites. The study 
found that line performance (yield) was mainly driven by survival. MSX and Dermo 
were proposed to be the main drivers behind the high mortality of northern lines in the 
Delaware and Chesapeake Bay sites. Supplementary figure 1 shows the cumulative 
mortality graph of the six oyster lines. 
      This study provides a good opportunity to conduct association studies for disease 
resistance since we have samples collected before and after mortality events to serve 
as control and case groups. Samples collected before mortality can be considered as 
the control population, which largely consists of susceptible oysters, with some 
resistant oysters in the mix. Samples collected after mortality can be considered as the 
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case population, as they had undergone selection from disease.  When choosing which 
oyster line and site to use for this project, two criteria were used: 1) Oyster population 
with high mortality is preferred, since the selection on the genetic marker loci by 
disease would be easier to identify. However, populations with 100% mortality should 
be avoided as there would be no case populations. 2) High MSX and/or Dermo 
prevalence and intensity during mortality period is preferred, for disease resistance is 
the trait we are interested in. Oyster lines in Maine site suffered high mortality early in 
the study from a ROD outbreak and no oysters were left, so Maine site is excluded. 
NEH-RI line had high mortality in both Virginia and New Jersey site and still had 
survivors at the end of the study (Figure 2). qPCR (Quantitative Polymerase Chain 
Reaction) data confirmed high prevalence and intensity of Dermo and MSX in the 
summer mortality period (Supplementary Table 1). Other lines/sites did not have as 
high mortality rates, so NEH-RI line at Virginia and New Jersey were chosen for this 
study.  
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Supplementary Figure 1. Cumulative mortality data for six lines of oysters deployed 
at five sites from Sept-2012 to Dec-2013. 
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Supplementary Figure 2. Cumulative percent mortality experienced by oysters from 
the NEH-RI line deployed from August 2012 to November 2013 in sites in Virginia 
(York River) and New Jersey (Cape Shore). 
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Supplementary Table 1. Dermo and MSX prevalence and intensity for NEH-RI line 
at Virginia and New Jersey site during summer mortality period. 
Site Time Number 
of 
Samples 
Tested 
Dermo 
Prevalence 
Dermo Avg. 
Log 
Concentration 
MSX 
Prevalence 
MSX Avg. Log 
Concentration 
Virginia Sept-
2013 
60 100% 5.06 58% 4.04 
New 
Jersey 
Sept-
2013 
9 100% 3.22 100% 3.1 
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Supplementary Table 2. Locus-by-locus pairwise difference for selected 
microsatellites between pre- and post- a disease related mortality event experienced by 
a population of NEH-RI oysters deployed in sites in Virginia (York River) and New 
Jersey (Cape May) (locus by locus AMOVA). Shaded results are statistically 
significant (p < 0.05) 
 Virginia New Jersey 
Locus FST p  FST p  
RUCV 3 0.011 0.4452 0.035 0.0306 
RUCV1 -0.005 0.8208 0.029 0.0597 
RUCV 46 0.033 0.0497 0.020 0.1171 
RUCV 28 0.011 0.3457 0.040 0.0083 
RUCV11 0.023 0.0769 0.021 0.0238 
RUCV27 0.014 0.3708 0.040 0.0105 
Cv02i23 -0.001 0.4979 0.024 0.0530 
RUCV66 0.031 0.0775 0.001 0.4450 
RUCV24 0.020 0.2117 0.017 0.1586 
Cvi2j24 0.006 0.2310 0.019 0.0235 
RUCV 68 0.024 0.2146 0.106 0.0004 
RUCV97 0.002 0.4394 0.016 0.0126 
Cvi2i4 0.022 0.0927 0.007 0.1385 
RUCV23 0.010 0.1481 -0.001 0.5089 
RUCV18 0.002 0.3838 0.083 0.0023 
RUCV 270 0.024 0.2021 0.047 0.0230 
Cvi1g3 0.023 0.1022 -0.002 0.5114 
Cvi1g4 0.012 0.3648 0.003 0.4672 
RUCV58 -0.010 0.8974 -0.001 0.5335 
Cvi2m10 0.031 0.0282 0.009 0.1669 
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